Koers AntriaBio Inc OTC Bulletin Board
Aandelen
US0372301095
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
22/05 | Top stijgers premarket | MT |
21/05 | Transcript : Rezolute, Inc. - Special Call |
Omzet 2024 * | - | Omzet 2025 * | 23,49 mln. 21,66 mln. | Marktkapitalisatie | 162 mln. 149 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -63 mln. -58,09 mln. | Nettowinst (verlies) 2025 * | -49 mln. -45,18 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 86 mln. 79,3 mln. | Nettoliquiditeiten 2025 * | 68 mln. 62,7 mln. | EV/omzet 2025 * | 3,99 x |
K/w-verhouding 2024 * |
-3,44
x | K/w-verhouding 2025 * |
-5,14
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 79,6% |
Recentste transcriptie over AntriaBio Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 66 | 26-07-10 | |
Nevan Elam
CEO | Chief Executive Officer | 56 | 26-07-10 |
Daron Evans
DFI | Director of Finance/CFO | 50 | 24/01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nevan Elam
CEO | Chief Executive Officer | 56 | 26-07-10 |
Young-Jin Kim
BRD | Director/Board Member | 67 | 10-02-19 |
Gil Labrucherie
BRD | Director/Board Member | 52 | 20-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |
- Beurs
- Aandelen
- Koers RZLT
- Koers